Adherence to and dosing of beta-hydroxy-beta-methyl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes

AH Maitland - van der Zee; Bruno Stricker; OH Klungel; AK Mantel-Teeuwisse; JJP Kastelein; Bert Hofman; HGM Leufkens; Cornelia Duijn; A Boer

doi:10.1097/01.fpc.0000054080.64000.f1

Adherence to and dosing of beta-hydroxy-beta-methyl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes

AH Maitland - van der Zee, Bruno Stricker, OH Klungel, AK Mantel-Teeuwisse, JJP Kastelein, Bert Hofman, HGM Leufkens, Cornelia Duijn, A Boer

Epidemiology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	219-223
Number of pages	5
Journal	Pharmacogenetics
Volume	13
DOIs	https://doi.org/10.1097/01.fpc.0000054080.64000.f1
Publication status	Published - 2003

Research programs

EMC NIHES-01-64-03
EMC NIHES-03-77-02

Access to Document

10.1097/01.fpc.0000054080.64000.f1

http://hdl.handle.net/1765/5974

Cite this

Maitland - van der Zee, AH., Stricker, B., Klungel, OH., Mantel-Teeuwisse, AK., Kastelein, JJP., Hofman, B., Leufkens, HGM., Duijn, C., & Boer, A. (2003). Adherence to and dosing of beta-hydroxy-beta-methyl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes. Pharmacogenetics, 13, 219-223. https://doi.org/10.1097/01.fpc.0000054080.64000.f1

@article{422d8c69828445628ef7e593f29117fa,

title = "Adherence to and dosing of beta-hydroxy-beta-methyl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes",

author = "{Maitland - van der Zee}, AH and Bruno Stricker and OH Klungel and AK Mantel-Teeuwisse and JJP Kastelein and Bert Hofman and HGM Leufkens and Cornelia Duijn and A Boer",

year = "2003",

doi = "10.1097/01.fpc.0000054080.64000.f1",

language = "Undefined/Unknown",

volume = "13",

pages = "219--223",

journal = "Pharmacogenetics",

issn = "0960-314X",

publisher = "Lippincott Williams & Wilkins",

}

Maitland - van der Zee, AH, Stricker, B, Klungel, OH, Mantel-Teeuwisse, AK, Kastelein, JJP, Hofman, B, Leufkens, HGM, Duijn, C & Boer, A 2003, 'Adherence to and dosing of beta-hydroxy-beta-methyl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes', Pharmacogenetics, vol. 13, pp. 219-223. https://doi.org/10.1097/01.fpc.0000054080.64000.f1

TY - JOUR

T1 - Adherence to and dosing of beta-hydroxy-beta-methyl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes

AU - Maitland - van der Zee, AH

AU - Stricker, Bruno

AU - Klungel, OH

AU - Mantel-Teeuwisse, AK

AU - Kastelein, JJP

AU - Hofman, Bert

AU - Leufkens, HGM

AU - Duijn, Cornelia

AU - Boer, A

PY - 2003

Y1 - 2003

U2 - 10.1097/01.fpc.0000054080.64000.f1

DO - 10.1097/01.fpc.0000054080.64000.f1

M3 - Article

SN - 0960-314X

VL - 13

SP - 219

EP - 223

JO - Pharmacogenetics

JF - Pharmacogenetics

ER -